{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:57:09Z","timestamp":1790269029569,"version":"4.1.0"},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2023,5,1]]},"abstract":"<jats:p>This Viewpoint reports on the results of the Clarity AD trial, a phase 3 randomized clinical trial of lecanemab for patients with early Alzheimer disease, in which lecanemab\u2019s clinical efficacy was demonstrated using well-established outcome measures.<\/jats:p>","DOI":"10.1001\/jamaneurol.2023.0123","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T15:03:56Z","timestamp":1678719836000},"page":"429","source":"Crossref","is-referenced-by-count":18,"title":["A Step Forward in the Fight Against Dementia\u2014Are We There Yet?"],"prefix":"10.1001","volume":"80","author":[{"given":"David A.","family":"Wolk","sequence":"first","affiliation":[{"name":"Penn Alzheimer\u2019s Disease Research Center, Perelman School of Medicine, Department of Neurology, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil D.","family":"Rabinovici","sequence":"additional","affiliation":[{"name":"Weill Institute for Neurosciences, Memory and Aging Center, Alzheimer\u2019s Disease Research Center, Department of Neurology, University of California, San Francisco, San Francisco"},{"name":"Department of Radiology & Biomedical Imaging, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford C.","family":"Dickerson","sequence":"additional","affiliation":[{"name":"Frontotemporal Disorders Unit, Alzheimer\u2019s Disease Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"nvp230001r1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease.","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"18","key":"nvp230001r2","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer\u2019s disease.","volume":"384","author":"Mintun","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"nvp230001r3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease.","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"issue":"2","key":"nvp230001r4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","article-title":"Impact of multiple pathologies on the threshold for clinically overt dementia.","volume":"134","author":"Kapasi","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"1","key":"nvp230001r5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ana.v85.1","article-title":"Attributable risk of Alzheimer\u2019s dementia attributed to age-related neuropathologies.","volume":"85","author":"Boyle","year":"2019","journal-title":"Ann Neurol"},{"key":"nvp230001r6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2215148","article-title":"Multiple cerebral hemorrhages in a patient receiving lecanemab and treated with t-PA for stroke.","author":"Reish","journal-title":"N Engl J Med"},{"issue":"9","key":"nvp230001r7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.jacc.2017.07.724","article-title":"Cerebral amyloid angiopathy: diagnosis, clinical implications, and management strategies in atrial fibrillation.","volume":"70","author":"DeSimone","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2802273\/jamaneurology_wolk_2023_vp_230001_1683210077.13286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T17:47:20Z","timestamp":1683568040000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2802273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2023.0123","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,1]]}}}